Browsing by Author "Besterman, Aaron D."

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    21st-Century Genetics in Psychiatric Residency Training: How Do We Get There?
    (American Medical Association, 2019-03-01) Besterman, Aaron D.; Moreno-De-Luca, Daniel; Nurnberger, John I., Jr.; Psychiatry, School of Medicine
  • Thumbnail Image
    Item
    Dr Nurnberger and Colleagues Reply
    (Physicians Postgraduate Press, Inc., 2019-04-09) Jr., John I. Nurnberger; Austin, Jehannine; Berrettini, Wade H.; Besterman, Aaron D.; DeLisi, Lynn E.; Grice, Dorothy E.; Kennedy, James L.; Moreno-De-Luca, Daniel; Potash, James B.; Ross, David A.; Psychiatry, School of Medicine
  • Thumbnail Image
    Item
    What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics.
    (CME Institute of Ph​ysicians P​ostgraduate Press, Inc., 2018-11-27) Nurnberger, John I., Jr.; Austin, Jehannine; Berrettini, Wade H.; Besterman, Aaron D.; DeLisi, Lynn E.; Grice, Dorothy E.; Kennedy, James L.; Moreno-De-Luca, Daniel; Potash, James B.; Ross, David A.; Schulze, Thomas G.; Zai, Gwyneth; Psychiatry, School of Medicine
    The International Society of Psychiatric Genetics (ISPG) created a Residency Education Committee with the purpose of identifying key genetic knowledge that should be taught in psychiatric training programs. Thirteen committee members were appointed by the ISPG Board of Directors, based on varied training, expertise, gender, and national origin. The Committee has met quarterly for the past 2 years, with periodic reports to the Board and to the members of the Society. The information summarized includes the existing literature in the field of psychiatric genetics and the output of ongoing large genomics consortia. An outline of clinically relevant areas of genetic knowledge was developed, circulated, and approved. This document was expanded and annotated with appropriate references, and the manuscript was developed. Specific information regarding the contribution of common and rare genetic variants to major psychiatric disorders and treatment response is now available. Current challenges include the following: (1) Genetic testing is recommended in the evaluation of autism and intellectual disability, but its use is limited in current clinical practice. (2) Commercial pharmacogenomic testing is widely available, but its utility has not yet been clearly established. (3) Other methods, such as whole exome and whole genome sequencing, will soon be clinically applicable. The need for informed genetic counseling in psychiatry is greater than ever before, knowledge in the field is rapidly growing, and genetic education should become an integral part of psychiatric training.